Initial
Work-up Diagnosis
of MDS WHO/ICC
classification Prognostic Scoring:
WPSS Prognostic Scoring:
MPSS Prognostic Scoring
CCSS Prognostic Scoring:
IPSS-R Prognostic Scoring:
IPSS-M Prognostic Scoring:
MDS-FI Other Prognostic
Factors Potential Future
Factors MDS Predisposing
Conditions
Work-up Diagnosis
of MDS WHO/ICC
classification Prognostic Scoring:
WPSS Prognostic Scoring:
MPSS Prognostic Scoring
CCSS Prognostic Scoring:
IPSS-R Prognostic Scoring:
IPSS-M Prognostic Scoring:
MDS-FI Other Prognostic
Factors Potential Future
Factors MDS Predisposing
Conditions
- Incorporates cytopenias, cytogenetics, BM blast count
- Validated only for newly-diagnosed primary MDS*
| IPSS for MDS: Survival and AML Evolution29 | |||||
|---|---|---|---|---|---|
| Score Value | |||||
| Prognostic Variable | 0 | 0.5 | 1.0 | 1.5 | 2.0 |
| BM blasts (%) | <5 | 5-10 | - | 11-20 | 21-30 |
| Karyotype* | Good | Intermediate | Poor | ||
| Cytopenias† | 0/1 | 2/3 | |||
*Good = normal, -Y, del(5q), del(20q)
Poor = complex (≥3 abnormalities) or chromosome 7 anomalies
Intermediate = Other abnormalities (including +8, single miscellaneous, double abnormalities)
†Cytopenias were defined as a hemoglobin level of less than 100 g/L,
an absolute neutrophil count of less than 1.5 x 109/L, and a platelet count of less than 100 x
109/L.
| Risk Category | Score | |
|---|---|---|
| Lower-risk MDS | Low risk | 0 |
| Intermediate-1 risk | 0.5-1.0 | |
| Higher-risk MDS | Intermediate-2 risk | 1.5-2.0 |
| High risk | ≥2.5 | |